macman1519 wrote: Wrong Bencro. There is no other company in our situation, zip, none! So quit comparing it to companies with revenues. We have something far more valuable and therefor priceless. We have a cancer killer, 100% success, any other company with those results???? Any?????? Even this early, any???? So quit undervaluing this company for ur buddy frost!!!! Priceless that is what the cure for cancer is!!!!* see what big pharma thinks of us if we put up the for salesign, a bidding war like no other, share price appreciation, like never before seen in an extremely short time, manipulation, what manipulation. And Theralase will be a household word. So please, Bencro, dont compare this to any other company. There is none. Management chooses to think small, to think conservatively, to play into frosts hands. Hmmmmm, wonder why????? Just put it up for sale, not hard to do, and see what happens. What is the downside, Roger, let us know the downside to this strategy from one of your mouthpieces on this board. So far all theyve managed to do is shoot the messanger, but ignore the message. Please anyone, what is the downside when you dont have to sell, and all the other positive things have occurred. Oh yea, frost will be unhappy, too friggin bad, Roger. Put the thing up for sale or tell us why it is such a terrible idea. U too bencro, awfully quiet concerning this strategy, whats the downside. U are great feeding us study after study, for the past three years , you have been stay the course, rediculously low pps, stay the courseand no share appreciation for the last three years. Now you have stated two to three more years. Interesting that your time lines have shortened recently, Hmm, no longer three years now ur talking two years, and now six months. Just enough time for another low pp, huh. Carefull bencro, your true colors are showing!!!! From three years to now six months and the stock price will get much better, we've heard that before, just wait till the safety results come out, just wait till the efficacy results come out. We waited and the manipulation took us down. Great advice!!! Just wait wait wait, till frost buys more and more, right. You want a proper evaluation, only one way to get it. Let the market decide. No other company is in our situation. We have the hammer. Buy putting it up for sale we force big pharma to show their hands. Are we afraid to find out????? Are we fearful we are a fraud, totally wothless toilet paper????? Do you believe in this company????? If you believe in our results, so does big pharma have to believe. They can not let us go to a competitor for a song and a dance. Roger, put us up for sale and see what the market thinks of us and what that simple strategy does to our share price, warrants, buzzz. Or are you already committed to frost. Small mindedness always gets in the way of greatness!!!!!!
uote=bencro]
Ponching ... Good post.
Assuming NMIBC approval, one good conservative valuation comparison could be BioMarin, given your numbers.
BioMarin (BMRN:US)
Biomarin Pharmaceutical Inc is on rare-disease therapies. It develops and commercializes pharmaceuticals for serious diseases and medical conditions.
Revenues:
... 3-months = 317.4M$
... 6-months = 621.2M$
... 12-months = 1.2B$
Stock price: 89.40$
Shares Out.: 174,490,025 (TLT now: 124,231,526)
Market cap: 15.6G$ (TLT now = 58M$ ... 268x less than Biomarin)
Interesting also that you include P/E ratios (15x) in your equation. Acceptabe and conservative, when compared to these:
- Merck ... 35x P/E
- BMS ... 20x P/E
- Roche ... 22x P/E
- Pfizer ... 27x P/E
- AstraZeneca ... 20x P/E
- etc ...
_______________________
Your original post:
Valuation anyone?
According to Roger White, the bladder cancer's revenue opportunity in the US alone is $3billion and an additional $9billion the rest of the world.
Conservatively, 1 out of 4 patients would prefer the Theralase treatment so this could mean an annual revenue before expenses of $3billions for the company alone.
P/E ratio of 15x should put us at $60billion market cap easily and let's just say we did end up with 200million shares from PP. This should put us at $225/share in 2-3years and I'll take that with a big smile. AND if 2 out of 4 patients prefer Theralase treatment?? well $450/share is not that far. Note that we are only at 135mil shares (fully dilluted) so my estimates are really conservative.
Now to make it even better... Note that Theralase has another product for brain cancer which is also promising and I'm guessing it will start the Phase 1 after the commercialization of the NMIB Theralase cure. This brain cancer cure by Therelase can prolong the life of a patient by 5 years - 8 years compared to the current cure that only prolongs a patient's life by a year or so.. NOW that is a major changer too.
Lol don't worry I didn't make this up.. .here's the link of the interview.
https://www.youtube.com/watch?v=0YduNy4_9A8